Tivic Health Strengthens IP Protection: Sixth Patent Issued for Bioelectronic Platform

August 1, 2023


Tivic Health, a leading bioelectronic company, is proud to announce the issuance of its sixth patent, further reinforcing its intellectual property (IP) protection for its innovative bioelectronic platform. This development reflects the company’s commitment to advancing medical technology and expanding its influence in the healthcare industry.


  1. Elevating IP Protection: With the issuance of its sixth patent, Tivic Health secures a strong foundation for safeguarding its pioneering bioelectronic platform. This move ensures exclusive rights to its cutting-edge technology and positions the company as a leader in the evolving field of bioelectronics.
  2. Advancing Medical Technology: The patented bioelectronic platform by Tivic Health signifies a leap forward in medical technology. By leveraging innovative solutions, the company aims to enhance patient care and contribute to improved treatment options for a wide range of medical conditions.
  3. Empowering Healthcare Industry: Tivic Health’s expanding IP portfolio empowers the healthcare industry by offering novel therapeutic options. The bioelectronic platform has the potential to revolutionize healthcare delivery, leading to more efficient and personalized patient outcomes.
  4. Driving Growth and Innovation: With a strong IP protection strategy, Tivic Health gains a competitive advantage in attracting investors, partners, and talent. This, in turn, fuels further growth, research, and development, allowing the company to push the boundaries of bioelectronics and medical science.
  5. Impact on Patients: The issuance of the sixth patent reinforces Tivic Health’s dedication to improving the lives of patients. By securing their technological advancements, the company can focus on delivering effective and safe treatments to address unmet medical needs.

Leave a Comment